PIL against price cap on RT-PCR tests at Rs 800: HC seeks Delhi Govt's response
The association, which filed the plea urged the court to quash the Delhi government order saying that it is seriously affecting the rights of private laboratories run by its members and causing financial losses every day.;
New Delhi: The Delhi High Court on Friday issued a notice to the Delhi government on a petition against the latter's decision to cap the cost of the reverse transcription-polymerase chain reaction (RT-PCR) test for Covid-19 at Rs 800.
A single-judge bench of Justice Navin Chawla asked the Delhi government to file a reply on the petition filed by the Association of Practicing Pathologists. The bench listed the matter for further hearing on February 25.
Also Read: Disposal of used COVID test kits: Delhi HC asks State if any guidelines in place
The association, which filed the plea through advocate Neeraj Grover, urged the court to quash the Delhi government order saying that it is seriously affecting the rights of private laboratories run by its members and causing financial losses every day.
The plea said that the Delhi government has arbitrarily and without any authority of law fixed the ceiling price on charges of RT-PCR based molecular tests for Covid-19 in Delhi by the private sector labs, thereby violating several fundamental rights of the members of the petitioner association guaranteed by the Constitution of India under Article 14, 19 ( 1) (g) and violating the fundamental rights of the common man under Article 21.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.